title: Recent advances in medical dermatology.
abstract: Collectively, new developments in the field of medical dermatology will ultimately lead to improved patient care. We review several new findings in the dermatologic literature including the following: new questions regarding the malignant potential of anti-tumor necrosis factor agents, which are widely used for the treatment of moderate to severe psoriasis as well as psoriatic arthritis; anti-interleulin-12, a promising anticytokine for the treatment of psoriasis; diagnostic advances in the detection of latent Mycobacterium tuberculosis; advances in the primary prevention of human papillomavirus and herpes zoster; and new therapeutic options with existing medications for neuropathic pain and pruritus.
authors.affiliation: Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA. lily.clark@mssm.edu
authors.forename: Lily N
authors.initials: LN
authors.lastname: Clark
authors.forename: Mark
authors.initials: M
authors.lastname: Lebwohl
mesh_terms: D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003880:Dermatology / Q000379:methods* / Q000639:trends; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D053061:Herpes Zoster Vaccine; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D018664:Interleukin-12 / Q000037:antagonists & inhibitors; D009161:Mycobacterium / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000175:diagnosis; D010146:Pain / Q000188:drug therapy; D053918:Papillomavirus Vaccines; D011565:Psoriasis / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D003879:Dermatologic Agents; D053061:Herpes Zoster Vaccine; D007155:Immunologic Factors; D053918:Papillomavirus Vaccines; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12